These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9334716)

  • 1. A new role for an old actor.
    Wagner JA; Burd P
    Nat Med; 1997 Oct; 3(10):1084-5. PubMed ID: 9334716
    [No Abstract]   [Full Text] [Related]  

  • 2. Moral authority.
    Nature; 2013 Jun; 498(7452):5-6. PubMed ID: 23745195
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health.
    Hum Gene Ther; 2001 Nov; 12(17):2129-51. PubMed ID: 11747602
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 5. The RAC: double, double, toil, and trouble?
    Ertl H
    Mol Ther; 2009 Mar; 17(3):397-9. PubMed ID: 19247363
    [No Abstract]   [Full Text] [Related]  

  • 6. NIH and FDA seek to increase oversight of gene therapy research.
    J Investig Med; 2000 May; 48(3):169-71. PubMed ID: 10822896
    [No Abstract]   [Full Text] [Related]  

  • 7. Supervising gene therapy, openly.
    Lancet; 1997 Jul; 350(9071):79. PubMed ID: 9228953
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapy trials face further scrutiny.
    Greener M
    Mol Med Today; 2000 Jun; 6(6):211. PubMed ID: 10840374
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
    Perry LA; Penny-Dimri JC; Aslam AA; Lee TW; Southern KW
    Paediatr Respir Rev; 2017 Mar; 22():47-49. PubMed ID: 27964951
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung.
    Crystal RG; Jaffe A; Brody S; Mastrangeli A; McElvaney NG; Rosenfeld M; Chu CS; Danel C; Hay J; Eissa T
    Hum Gene Ther; 1995 May; 6(5):643-66. PubMed ID: 7578401
    [No Abstract]   [Full Text] [Related]  

  • 11. What did we learn from the North American Cystic Fibrosis Conference?
    Bilton D
    J R Soc Med; 2008 Jul; 101 Suppl 1(Suppl 1):S6-9. PubMed ID: 18607012
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy on trial.
    Marshall E
    Science; 2000 May; 288(5468):951-7. PubMed ID: 10841710
    [No Abstract]   [Full Text] [Related]  

  • 13. Cystic fibrosis gene therapy: the first trial.
    Arch Dis Child; 2015 Sep; 100(9):844. PubMed ID: 26205882
    [No Abstract]   [Full Text] [Related]  

  • 14. RAC ponders its purpose: to be or not to be.
    Jenks S
    J Natl Cancer Inst; 1993 Oct; 85(19):1544-6. PubMed ID: 8411224
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential.
    Elborn JS; Davies J
    Lancet Respir Med; 2017 Sep; 5(9):681-683. PubMed ID: 28853396
    [No Abstract]   [Full Text] [Related]  

  • 16. In utero efficacy of cystic fibrosis gene therapy: difficult studies, positive or negative.
    Flotte TR
    Mol Ther; 2008 May; 16(5):806-7. PubMed ID: 18432269
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of CF gene therapy.
    Boucher RC
    Trends Genet; 1996 Mar; 12(3):81-4. PubMed ID: 8868343
    [No Abstract]   [Full Text] [Related]  

  • 18. [New therapeutic approaches in cystic fibrosis].
    Vestner A; Schrepfer B; Kockler J; Mohr F; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):354-5. PubMed ID: 18729285
    [No Abstract]   [Full Text] [Related]  

  • 19. Human gene therapy: science under fire.
    SoRelle R
    Circulation; 2000 Mar; 101(12):E9023-4. PubMed ID: 10736304
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.
    Hum Gene Ther; 2002 Jan; 13(1):3-13. PubMed ID: 11779411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.